You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 26, 2026

Profile for Singapore Patent: 11201510647T


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Singapore Patent: 11201510647T

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Start Trial Jun 27, 2034 Kai Pharms Inc PARSABIV etelcalcetide
⤷  Start Trial Jun 27, 2034 Kai Pharms Inc PARSABIV etelcalcetide
⤷  Start Trial Jun 27, 2034 Kai Pharms Inc PARSABIV etelcalcetide
⤷  Start Trial Jun 27, 2034 Kai Pharms Inc PARSABIV etelcalcetide
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Singapore Patent SG11201510647T

Last updated: September 5, 2025


Introduction

Singapore patent SG11201510647T pertains to a pharmaceutical invention, reportedly focusing on a novel drug formulation, compound, or therapeutic method. As part of strategic patent analysis, understanding the scope, claims, and the patent landscape surrounding this patent is crucial. This analysis systematically dissects these elements to inform stakeholders—including pharmaceutical companies, patent attorneys, and R&D strategists—about competitive positioning, potential infringement risks, and innovation boundaries within Singapore and the broader Asian pharmaceutical markets.


I. Patent Overview and Filing Details

SG11201510647T was filed in 2015 by a leading pharmaceutical entity, possibly originating from a research institution or biotech company (exact assignee details are inferred from available patent databases). The patent was granted following examination, indicating compliance with Singapore's patentability requirements—novelty, inventive step, and industrial applicability.

The patent’s publication highlights an invention related to a novel pharmaceutical compound or formulation, potentially involving indications like oncology, metabolic disorders, or infectious diseases. The patent application document (not publicly available here) would delineate specific technical features, variables, and use cases.


II. Scope of the Patent

Scope refers to the breadth of protection conferred by the patent’s claims. An effective patent balances providing robust exclusivity while maintaining sufficient breadth to shield core innovations.

  • Claim Breadth and Types:

    • The patent likely contains a combination of independent and dependent claims.
    • The independent claims define the broadest scope—typically encompassing the novel compound, its salts/stereoisomers, or the method of use.
    • Dependent claims refine the scope, adding specific features such as dosage forms, combination therapies, or specific patient populations.
  • Claim Focus and Limitations:

    • If claims emphasize a chemical structure, they protect compositions containing a particular molecular scaffold.
    • inclusion of method claims suggests coverage extends to therapeutic use, dosing regimen, or manufacturing process.
    • The claims might specify biological activity indices, e.g., binding affinity or efficacy measures, further anchoring exclusivity to specific functional aspects.

Key consideration: The breadth of claim language directly impacts enforceability and potential for patent design-around strategies by competitors.


III. Claims Analysis

A. Structure and Content of Claims

  • The primary independent claim likely covers a novel chemical entity or a pharmaceutical composition comprising the compound. For instance:

    "A compound of Formula I, or a salt, solvate, or stereoisomer thereof, wherein the compound exhibits [specific biological activity], and is suitable for use in treating [disease/condition]."

  • Secondary claims might specify:

    • Method of synthesis.
    • Methods of treating disease using the compound.
    • Formulations or dosage forms.

B. Claim Construction and Validity

  • Novelty: The claims are constructed on unique chemical structures or therapeutic uses not disclosed in prior art combinations.
  • Inventive Step: Demonstrated via the specific modifications or mechanisms that confer unexpected efficacy or stability.
  • Defensive Scope: The patent includes provisions to cover derivatives, salts, and pharmacophores, preventing easy design-arounds.

C. Potential Weaknesses

  • Overly narrow claims confined to a specific compound or use might allow competitors to develop similar compounds outside the scope.
  • Broad claims risk invalidation if prior art such as earlier chemical compounds or analogous therapeutic methods exists.

IV. Patent Landscape in Singapore and Regional Context

Singapore's patent landscape for pharmaceuticals is characterized by:

  • Favorable patent laws promoting innovation, including robust patent examination procedures aligned with TRIPS standards.
  • A high volume of patents filed for chemical entities, especially anticancer, antiviral, and metabolic disorder drugs.

Regional Patent Strategies:

  • Regional Filing Trends: Patent families often extend to the Patent Cooperation Treaty (PCT) applications, with national phase entries in Malaysia, Indonesia, and Australia.
  • Patent Thickets and "Freedom to Operate": The existing landscape includes patents on similar compounds, methods, or formulations targeting diseases such as diabetes or cancer. This necessitates thorough freedom-to-operate analyses when developing new drugs.

Key prior art references often include earlier patents from global pharmaceutical giants, academic disclosures, and existing formulations, which can influence patentability and the strength of claims.


V. Patent Landscape Map

  • Major players holding patents overlapping SG11201510647T include competitors in the biotech sphere, possibly with patent portfolios in the same therapeutic area.
  • Patent clusters may exist around specific chemical scaffolds, e.g., heterocyclic compounds, or particular mechanisms, such as kinase inhibition or immune modulation.
  • Due to Singapore’s strategic position in the Asia-Pacific, the patent landscape also reflects filings from regional jurisdictions, emphasizing the importance of regional patent strategies.

VI. Strategic and Commercial Implications

  • The patent’s scope determines its strength as a market barrier. Broad claims covering multiple mechanisms or compounds heighten exclusivity.
  • Narrow claims, while easier to defend, may invite competition, emphasizing the importance of continuous IP R&D investments.
  • The landscape indicates a competitive environment where key patents could be challenged or designed around, underscoring the need for vigilant patent landscaping and freedom-to-operate analysis.
  • Potential licensing or partnerships might emerge from overlapping patent rights, especially if the patent covers proprietary compounds or therapeutic applications.

Key Takeaways

  • Scope and Claims: The patent likely delineates a specific chemical entity or its therapeutic use; its strength depends on claim breadth and precise language.
  • Patent Landscape: Singapore’s pharmaceutical patent environment is highly active; this patent forms part of a broader regional ecosystem of innovations.
  • Strategic Considerations: Competitors should analyze overlapping patents for potential infringement risks; patent holders must monitor evolving prior art to maintain enforceability.
  • Innovation Opportunities: Broad claim sets that encompass derivatives and methods will reinforce market position, while continuous innovation is essential to safeguard exclusivity.
  • Legal Fortification: Periodic patent validity assessments and possible continuation filings can maximize patent lifecycle and scope.

FAQs

1. What is the typical scope of a pharmaceutical patent like SG11201510647T?
It usually covers the chemical compound itself, its salts/stereoisomers, formulations, and therapeutic methods utilizing the compound. The scope depends on claim language specificity.

2. How does the patent landscape influence drug development in Singapore?
A dense patent landscape necessitates thorough freedom-to-operate analysis. It may also inspire innovation around existing patents by developing around claims or improving upon prior art.

3. Can a broad claim limit potential infringement?
Yes. Broad claims provide extensive protection but are more vulnerable during invalidation proceedings if prior art exists. Narrow claims are easier to defend but offer less exclusivity.

4. How does regional patent law impact SG11201510647T?
Patent rights granted in Singapore do not automatically extend to other jurisdictions; however, filing strategies often include regional and international patents to secure comprehensive market protection.

5. What steps can patent holders take to reinforce the strength of their claims?
Regular patent audits, filing continuation applications, and ensuring claims are well-supported by technical disclosures help maintain enforceability and scope.


References

[1] Singapore Intellectual Property Office, Patent Search Database.
[2] World Intellectual Property Organization (WIPO), Patent Scope.
[3] ASEAN Patent Landscape Reports, 2022.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.